145 related articles for article (PubMed ID: 23719953)
1. Circulating microRNAs in the cerebrospinal fluid of patients with brain diseases.
Machida A; Ohkubo T; Yokota T
Methods Mol Biol; 2013; 1024():203-9. PubMed ID: 23719953
[TBL] [Abstract][Full Text] [Related]
2. A Customized Quantitative PCR MicroRNA Panel Provides a Technically Robust Context for Studying Neurodegenerative Disease Biomarkers and Indicates a High Correlation Between Cerebrospinal Fluid and Choroid Plexus MicroRNA Expression.
Wang WX; Fardo DW; Jicha GA; Nelson PT
Mol Neurobiol; 2017 Dec; 54(10):8191-8202. PubMed ID: 27900678
[TBL] [Abstract][Full Text] [Related]
3. A model for data analysis of microRNA expression in forensic body fluid identification.
Wang Z; Luo H; Pan X; Liao M; Hou Y
Forensic Sci Int Genet; 2012 May; 6(3):419-23. PubMed ID: 21903498
[TBL] [Abstract][Full Text] [Related]
4. Regulated microRNAs in the CSF of patients with multiple sclerosis: a case-control study.
Haghikia A; Haghikia A; Hellwig K; Baraniskin A; Holzmann A; Décard BF; Thum T; Gold R
Neurology; 2012 Nov; 79(22):2166-70. PubMed ID: 23077021
[TBL] [Abstract][Full Text] [Related]
5. Methods of microRNA quantification in urinary sediment.
Wang G; Szeto CC
Methods Mol Biol; 2013; 1024():211-20. PubMed ID: 23719954
[TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal fluid biomarkers of neurodegeneration in chronic neurological diseases.
Tumani H; Teunissen C; Süssmuth S; Otto M; Ludolph AC; Brettschneider J
Expert Rev Mol Diagn; 2008 Jul; 8(4):479-94. PubMed ID: 18598229
[TBL] [Abstract][Full Text] [Related]
7. Analysis of miRNA Signatures in Neurodegenerative Prion Disease.
Bellingham SA; Hill AF
Methods Mol Biol; 2017; 1658():67-80. PubMed ID: 28861783
[TBL] [Abstract][Full Text] [Related]
8. Circulating microRNA for the identification of forensically relevant body fluids.
Hanson EK; Ballantyne J
Methods Mol Biol; 2013; 1024():221-34. PubMed ID: 23719955
[TBL] [Abstract][Full Text] [Related]
9. [CSF biomarkers: proteomics investigations and clinical applications in neurodegenerative disorders].
Gabelle A; Roche S; Lehmann S
Rev Neurol (Paris); 2009 Mar; 165(3):213-22. PubMed ID: 18808768
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA Profiling of Alzheimer's Disease Cerebrospinal Fluid.
Denk J; Jahn H
Methods Mol Biol; 2018; 1750():93-107. PubMed ID: 29512067
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA isolation and quantification in cerebrospinal fluid: A comparative methodical study.
Kopkova A; Sana J; Fadrus P; Machackova T; Vecera M; Vybihal V; Juracek J; Vychytilova-Faltejskova P; Smrcka M; Slaby O
PLoS One; 2018; 13(12):e0208580. PubMed ID: 30532175
[TBL] [Abstract][Full Text] [Related]
12. Assessing sample and miRNA profile quality in serum and plasma or other biofluids.
Blondal T; Jensby Nielsen S; Baker A; Andreasen D; Mouritzen P; Wrang Teilum M; Dahlsveen IK
Methods; 2013 Jan; 59(1):S1-6. PubMed ID: 23036329
[TBL] [Abstract][Full Text] [Related]
13. Characterization of Alzheimer's Disease Micro-RNA Profile in Exosome-Enriched CSF Samples.
Riancho J; Santurtun A; Sánchez-Juan P
Methods Mol Biol; 2019; 2044():343-352. PubMed ID: 31432424
[TBL] [Abstract][Full Text] [Related]
14. MiRNA profiles in cerebrospinal fluid from patients with central hypersomnias.
Holm A; Bang-Berthelsen CH; Knudsen S; Modvig S; Kornum BR; Gammeltoft S; Jennum PJ
J Neurol Sci; 2014 Dec; 347(1-2):199-204. PubMed ID: 25451005
[TBL] [Abstract][Full Text] [Related]
15. Analysis of circulating microRNA by microarray in liver disease.
Murakami Y; Tanahashi T
Methods Mol Biol; 2013; 1024():173-82. PubMed ID: 23719950
[TBL] [Abstract][Full Text] [Related]
16. Screening and confirmation of microRNA markers for forensic body fluid identification.
Wang Z; Zhang J; Luo H; Ye Y; Yan J; Hou Y
Forensic Sci Int Genet; 2013 Jan; 7(1):116-23. PubMed ID: 22909992
[TBL] [Abstract][Full Text] [Related]
17. Cerebrospinal fluid biomarkers in neurological diseases in children.
Shahim P; Månsson JE; Darin N; Zetterberg H; Mattsson N
Eur J Paediatr Neurol; 2013 Jan; 17(1):7-13. PubMed ID: 23026858
[TBL] [Abstract][Full Text] [Related]
18. Small RNAs have a large impact: circulating microRNAs as biomarkers for human diseases.
Weiland M; Gao XH; Zhou L; Mi QS
RNA Biol; 2012 Jun; 9(6):850-9. PubMed ID: 22699556
[TBL] [Abstract][Full Text] [Related]
19. Accuracy of a panel of 5 cerebrospinal fluid biomarkers in the differential diagnosis of patients with dementia and/or parkinsonian disorders.
Hall S; Öhrfelt A; Constantinescu R; Andreasson U; Surova Y; Bostrom F; Nilsson C; Håkan W; Decraemer H; Någga K; Minthon L; Londos E; Vanmechelen E; Holmberg B; Zetterberg H; Blennow K; Hansson O
Arch Neurol; 2012 Nov; 69(11):1445-52. PubMed ID: 22925882
[TBL] [Abstract][Full Text] [Related]
20. The Study of Cerebrospinal Fluid microRNAs in Spinal Cord Injury and Neurodegenerative Diseases: Methodological Problems and Possible Solutions.
Baichurina I; Valiullin V; James V; Rizvanov A; Mukhamedshina Y
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
